Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2210120017 | Category: Pharma & Healthcare | Pages: 96 | Format: PDF | Published Date: November 04,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Diphtheria, Tetanus, and Pertussis Combined Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Million Doses), and average selling prices (USD/Dose), 2017-2028
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million Doses), and average selling prices (USD/Dose), 2017-2028
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million Doses), and average selling prices (USD/Dose), 2017-2028
Global Diphtheria, Tetanus, and Pertussis Combined Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Million Doses), and ASP (USD/Dose), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diphtheria, Tetanus, and Pertussis Combined Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diphtheria, Tetanus, and Pertussis Combined Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics and Wuhan Institute of Biological Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Diphtheria, Tetanus, and Pertussis Combined Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Inactivated Vaccine
    Other
Market segment by Application
    12 Months Below
    12 Months Above
Major players covered
    Sanofi Pasteur
    GSK
    Mitsubishi Tanabe Pharma
    KM Biologics
    Wuhan Institute of Biological Products
    Walvax Biotechnology
    Chengdu Institute of Biological Products
    Minhai Biotechnology
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diphtheria, Tetanus, and Pertussis Combined Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, with price, sales, revenue and global market share of Diphtheria, Tetanus, and Pertussis Combined Vaccine from 2017 to 2022.
Chapter 3, the Diphtheria, Tetanus, and Pertussis Combined Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diphtheria, Tetanus, and Pertussis Combined Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Diphtheria, Tetanus, and Pertussis Combined Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Diphtheria, Tetanus, and Pertussis Combined Vaccine.
Chapter 14 and 15, to describe Diphtheria, Tetanus, and Pertussis Combined Vaccine sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Introduction
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Type: 2017 Versus 2021 Versus 2028
        1.3.2 Inactivated Vaccine
        1.3.3 Other
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Application: 2017 Versus 2021 Versus 2028
        1.4.2 12 Months Below
        1.4.3 12 Months Above
    1.5 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size & Forecast
        1.5.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value (2017 & 2021 & 2028)
        1.5.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity (2017-2028)
        1.5.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price (2017-2028) 
2 Manufacturers Profiles
    2.1 Sanofi Pasteur
        2.1.1 Sanofi Pasteur Details
        2.1.2 Sanofi Pasteur Major Business
        2.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.1.5 Sanofi Pasteur Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.2.4 GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.2.5 GSK Recent Developments/Updates
    2.3 Mitsubishi Tanabe Pharma
        2.3.1 Mitsubishi Tanabe Pharma Details
        2.3.2 Mitsubishi Tanabe Pharma Major Business
        2.3.3 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.3.4 Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
    2.4 KM Biologics
        2.4.1 KM Biologics Details
        2.4.2 KM Biologics Major Business
        2.4.3 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.4.4 KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.4.5 KM Biologics Recent Developments/Updates
    2.5 Wuhan Institute of Biological Products
        2.5.1 Wuhan Institute of Biological Products Details
        2.5.2 Wuhan Institute of Biological Products Major Business
        2.5.3 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.5.4 Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
    2.6 Walvax Biotechnology
        2.6.1 Walvax Biotechnology Details
        2.6.2 Walvax Biotechnology Major Business
        2.6.3 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.6.4 Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.6.5 Walvax Biotechnology Recent Developments/Updates
    2.7 Chengdu Institute of Biological Products
        2.7.1 Chengdu Institute of Biological Products Details
        2.7.2 Chengdu Institute of Biological Products Major Business
        2.7.3 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.7.4 Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
    2.8 Minhai Biotechnology
        2.8.1 Minhai Biotechnology Details
        2.8.2 Minhai Biotechnology Major Business
        2.8.3 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product and Services
        2.8.4 Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.8.5 Minhai Biotechnology Recent Developments/Updates
3 Competitive Environment: Diphtheria, Tetanus, and Pertussis Combined Vaccine by Manufacturer
    3.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Manufacturer (2017-2022)
    3.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Manufacturer (2017-2022)
    3.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Manufacturer (2017-2022)
    3.4 Market Share Analysis (2021)
        3.4.1 Producer Shipments of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
        3.4.2 Top 3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Manufacturer Market Share in 2021
        3.4.2 Top 6 Diphtheria, Tetanus, and Pertussis Combined Vaccine Manufacturer Market Share in 2021
    3.5 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Region Footprint
        3.5.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Type Footprint
        3.5.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region
        4.1.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Region (2017-2028)
        4.1.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Region (2017-2028)
        4.1.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Region (2017-2028)
    4.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value (2017-2028)
    4.3 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value (2017-2028)
    4.4 Asia-Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value (2017-2028)
    4.5 South America Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value (2017-2028)
    4.6 Middle East and Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value (2017-2028)
5 Market Segment by Type
    5.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Type (2017-2028)
    5.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Type (2017-2028)
    5.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Application (2017-2028)
    6.2 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Application (2017-2028)
    6.3 Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price by Application (2017-2028)
7 North America
    7.1 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Type (2017-2028)
    7.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Application (2017-2028)
    7.3 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
        7.3.1 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Country (2017-2028)
        7.3.2 North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe
    8.1 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Type (2017-2028)
    8.2 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Application (2017-2028)
    8.3 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
        8.3.1 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Country (2017-2028)
        8.3.2 Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific
    9.1 Asia-Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Type (2017-2028)
    9.2 Asia-Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Application (2017-2028)
    9.3 Asia-Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region
        9.3.1 Asia-Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Region (2017-2028)
        9.3.2 Asia-Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America
    10.1 South America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Type (2017-2028)
    10.2 South America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Application (2017-2028)
    10.3 South America Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
        10.3.1 South America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Country (2017-2028)
        10.3.2 South America Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa
    11.1 Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Type (2017-2028)
    11.2 Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Application (2017-2028)
    11.3 Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Country
        11.3.1 Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Quantity by Country (2017-2028)
        11.3.2 Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Consumption Value by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Market Dynamics
    12.1 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
    12.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Restraints
    12.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Diphtheria, Tetanus, and Pertussis Combined Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Diphtheria, Tetanus, and Pertussis Combined Vaccine
    13.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Process
    13.4 Diphtheria, Tetanus, and Pertussis Combined Vaccine Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Distributors
    14.3 Diphtheria, Tetanus, and Pertussis Combined Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?